Trending News
News
News
LabCorp Licenses Technology for Early Detection of Lung Cancer from Duke University
LabCorp enters into an exclusive license agreement to commercialize Duke's new blood-based assay for early detection of lung cancer.
News
Common Molecule Notifies Immune System of Prostate Cancer
In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors.
News
Oncology Metrics and Cureline Announce Joint Marketing Agreement
Both companies have reached an agreement to collaborate on oncology biospecimen procurement and management.
News
Luminex Receives U.S. Food and Drug Administration Clearance for xTAG™ Respiratory Viral Panel
The Company has designed the test to simultaneously detect the most prevalent respiratory viruses.
News
Breast Cancer Cells Have to Learn to Walk Before they can Run
Early stage breast cancer that has not yet invaded the surrounding tissues may already contain highly motile cells, which brings the tumor one step closer to metastasis.
News
Pfizer to Acquire CovX to Extend Biotherapeutics Investment
Acquisition will provide biotherapeutics technology platform and complementary product candidates in oncology and diabetes.
News
Nicholas Piramal Enters into a Joint Venture with ARKRAY Inc Japan
The 49:51 joint venture aims at marketing diagnostic products, mainly self-monitoring blood glucose system in the Indian market.
News
BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology
Becton Dickinson has purchased an exclusive right to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform.
News
Cancer Cell Line Developed that is Resistant to new Cancer Therapy
Researchers found the HDAC inhibitor-resistant cell line resistant to many therapies but highly sensitive to heat shock protein 90 inhibitors, another emerging cancer treatment.
News
ImmunoVaccine Technologies to Acquire Immunotope
The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
Advertisement